10:45am ET
Health and Healthcare
Credit Suisse’s 4 Top Pharmaceutical Stocks to Buy for the Rest of 2014
A new report from the pharmaceutical team at Credit Suisse highlights four top stocks to buy for the remainder of 2014
Companies
/Healthcare
Abbvie Inc
$263.96
▼ $0.06 (−0.02%) today
Markets closed · 1:16am ET
ABBV Coverage
Page 42
8:40am ET
Health and Healthcare
AbbVie Earnings Take Back Seat to Shire Merger
AbbVie reported better-than-expected second-quarter 2014 results before markets opened Friday morning, due in part to strong sales of its Humira anti-inflammatory drug.
Paul Ausick 8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Alcatel-Lucent, Apple, FireEye, JDSU Uniphase, Solar Stocks and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Tuesday, July 2, 2014. They include Alcatel-Lucent, Apple, FireEye, JDSU Uniphase and solar stocks.
8:55am ET
Health and Healthcare
Analyst Cancer and Biotech Stock Picks From ASCO
ThinkstockAs the summer starts, a large agenda is out there for investors when it comes to top biotech and specialty pharmaceutical companies making announcements and presenting clinical data. The biggest health care…
8:20am ET
Health and Healthcare
Why You Buy Big Pharma If the Market Crashes
A new report from the global equity strategy team at Credit Suisse maintains that the best defensive sector now is large cap pharmaceuticals. Here are their top large cap pharmaceuticals to buy…
8:25am ET
Investing
Top Analyst Upgrades and Downgrades: eBay, GNC, Groupon, Hecla, J.C. Penney, Whole Foods and More
These are the top Wall Street analyst upgrades, downgrades and initiations for Wednesday, May 7, 2014. They include eBay, GNC, Groupon, Hecla Mining, J.C. Penney and Whole Foods.
11:20am ET
Retail
Why Target Shares Fell Rather Than Rose on CEO Firing
Shares of Target took a hit of around 3% Monday morning following the resignation/firing of CEO Gregg Steinhafel. The interim CEO and chairman do not seem like serious candidates for the job.
9:15am ET
Health and Healthcare
Baxter Split-Up, a Page From Abbott’s Playbook
Baxter International is taking an activist investor role of its own. The health care company has announced that it is splitting itself into two separate companies.
8:50am ET
Health and Healthcare
Jefferies’ Cheapest Health Care Stocks to Buy
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about…
8:50am ET
Health and Healthcare
Merrill Lynch’s Top Health Care Stocks to Buy Now
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top…
8:30am ET
Investing
Five Quantitative Analyst Stocks With Limited Emerging Markets Exposure
In Deutsche Bank's monthly quant view research piece, the firm looks for strategies that investors can implement to limit their exposure to emerging markets during this period of high uncertainty.
11:30am ET
Investing
Many Key Changes to Goldman Sachs Conviction Buy List for 2014
If one firm can create interest around a stock, it is Goldman Sachs. Investors have followed its Conviction Buy List for years, but 24/7 Wall St. has tracked many major changes to…
8:01am ET
Investing
Goldman Sachs Makes Major Conviction Buy List Changes for 2014
GS.COMIt is that time of year when investors start positioning their portfolios for the year ahead. 24/7 Wall St. reviews vast numbers of research reports looking for the best stocks to buy…
8:50am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, 3D Systems, Micron, Tesla and More
These are the top analyst upgrades, downgrades and initiations from select Wall Street research calls on Tuesday, December 3, 2013. They include Apple, 3D Systems, Micron Technology and Tesla Motors.
8:30am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, BBVA, Kors, PotBelly and More
Jon OggWe are in the thick of earnings season, a deal was made in D.C. and stocks are challenging new all-time highs almost daily. So how do investors know which stocks to…